共 118 条
[1]
Lipton RB(2016)A comparison of the Chronic Migraine Epidemiology and Outcomes (CaMEO) study and American Migraine Prevalence and Prevention (AMPP) study: demographics and headache-related disability Headache 56 1280-1289
[2]
Manack Adams A(2010)Current practice and future directions in the prevention and acute management of migraine Lancet Neurol 9 285-298
[3]
Buse DC(2002)CGRP may play a causative role in migraine Cephalalgia 22 54-61
[4]
Fanning KM(2010)CGRP and its receptors provide new insights into migraine pathophysiology Nat Rev Neurol 6 573-582
[5]
Reed ML(2014)Calcitonin gene-related peptide: physiology and pathophysiology Physiol Rev 94 1099-1142
[6]
Goadsby PJ(2013)CGRP and migraine: could PACAP play a role too? Neuropeptides 47 451-461
[7]
Sprenger T(2017)A controlled trial of erenumab for episodic migraine N Engl J Med 377 2123-2132
[8]
Lassen LH(2017)Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial Lancet Neurol 16 425-434
[9]
Haderslev PA(2016)Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial Lancet Neurol 15 382-390
[10]
Jacobsen VB(2014)Safety and efficacy of ALD403, an antibody to calciton in gene-related peptide, for the prevention of frequent episodic migraine: a randomised, double-blind, placebo-controlled, exploratory phase 2 trial Lancet Neurol 13 1100-1107